Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

C-PATROL - a Single Arm, Prospective Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer Population

NCT02503436 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02503436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02503436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
C-PATROL - a Single Arm, Prospective Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer Population
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 28, 2015
Completion date
December 1, 2022
Enrollment
276 (actual)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer, hereditary ovarian cancer syndrome